Junfei Wei

SARS‑CoV-2 RBD219-N1C1: A yeast-expressed SARS-CoV-2 recombinant receptor-binding domain candidate vaccine stimulates virus neutralizing antibodies and T-cell immunity in mice

Jeroen Pollet, Wen‐Hsiang Chen, Leroy Versteeg et al. · Human Vaccines & Immunotherapeutics · 2021 · 100 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

A yeast-expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates

María Pino, Talha Abid, Susan Pereira Ribeiro et al. · Science Immunology · 2021 · 82 citations · Full text

Pharmacy, Immunology, Infectious Diseases +17

Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate

Wen‐Hsiang Chen, Junfei Wei, Rakhi Kundu et al. · Biochimica et Biophysica Acta (BBA) - General Subjects · 2021 · 71 citations · Full text

Life Sciences, Biomolecular Engineering, Infectious Diseases +14

Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice

Viridiana Martínez-Campos, Pedro Pablo Martínez-Vega, María Jesús Ramírez-Sierra et al. · Vaccine · 2015 · 61 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease

Christopher A. Seid, Kathryn M. Jones, Jeroen Pollet et al. · Human Vaccines & Immunotherapeutics · 2016 · 60 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17